Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 55Neoplasms 15Sarcoma 12Neoplasm Metastasis 8Carcinoma, Non-Small-Cell Lung 6Triple Negative Breast Neoplasms 5Unspecified Adult Solid Tumor, Protocol Specific 3Prostatic Neoplasms 3Ovarian Neoplasms 3Sarcoma, Ewing 2Rhabdomyosarcoma 2Liposarcoma 2Leiomyosarcoma 2Carcinoma 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumors 1Salivary Gland Neoplasms 1Relapsed Solid Tumors 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Osteosarcoma 1Neurotoxicity Syndromes 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Lymphoma 1

Interventions

Doxorubicin 13Ifosfamide 10Radiotherapy 6Sunitinib 3pegfilgrastim 2Trabectedin 2Radiotherapy, Conformal 2Nivolumab 2Methotrexate 2Ipilimumab 2Imatinib Mesylate 2Filgrastim 2Etoposide 2Cisplatin 2Chemotherapy, Adjuvant 2tremelimumab 1temsirolimus 1soblidotin 1saracatinib 1romidepsin 1ribociclib 1reolysin 1perifosine 1pembrolizumab 1pazopanib 1olaratumab 1montanide ISA 51 1liposomal doxorubicin 1indolepropanol phosphate 1exatecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Histiocytoma, Malignant Fibrous × eribulin × Clear all
NCT03899805 2025-08-28

A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas

Dana-Farber Cancer Institute

Phase 2 Completed
57 enrolled 14 charts
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡